Similarly, a recent systematic review and meta-analysis involving 685 individuals with prediabetes and Type 2 diabetes revealed that ω-3 PUFA supplementation for a period of 12–24 weeks increased levels of adiponectin and reduced levels of a proinflammatory cytokine, TNFα [77]. Here, ADIPOQ is linked to type 2 diabetes mellitus.